Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Oct 15, 2024
Date Accepted: Mar 24, 2025

The final, peer-reviewed published version of this preprint can be found here:

Metabolic Flexibility to Predict Lifestyle Interventions Outcomes (MEPHISTO): Protocol for Predictive Validation Study and Randomized Controlled Trial

Ludlova M, Koudelkova K, Pallova J, Koudelkova B, Siklova M, Cahova M, Vetrovsky T, Šteffl M, Gojda J

Metabolic Flexibility to Predict Lifestyle Interventions Outcomes (MEPHISTO): Protocol for Predictive Validation Study and Randomized Controlled Trial

JMIR Res Protoc 2025;14:e67570

DOI: 10.2196/67570

PMID: 40340957

PMCID: 12099273

Metabolic flexibility to predict lifestyle interventions outcomes (MEPHISTO) - a protocol for a predictive validation study and randomized controlled trial

  • Monika Ludlova; 
  • Katerina Koudelkova; 
  • Jitka Pallova; 
  • Barbora Koudelkova; 
  • Michaela Siklova; 
  • Monika Cahova; 
  • Tomas Vetrovsky; 
  • Michal Šteffl; 
  • Jan Gojda

ABSTRACT

Background:

Weight loss is a cornerstone of diabetes mellitus type 2 (T2D) management, but its implementation in clinical practice is limited by its perceived burden and variability in response. Personalising interventions to increase their success rate is an unmet clinical need.

Objective:

Identification of predictive factors associated with successful weight loss after sequential exercise in women with obesity.

Methods:

The study will consist of a two-stage analytical approach including a predictive validation study and a 2:1 randomised cross-over controlled trial. Participants Women aged 25-45 years with obesity (BMI>30) will be included in the study. Intervention The intervention will consist of a progressive protocol of aerobic exercise on a treadmill and a bicycle ergometer. Outcomes FM/FFM weight loss, metabolic flexibility via ΔRQ (change in respiratory quotient (VCO2/VO2) between basal and insulin-stimulated state during glucose clamp), insulin sensitivity, glucose tolerance, HbA1c, microbiome composition, metabolomic signatures will be measured.

Results:

Recruitment for the trial began in January 2024. 12 participants were enrolled and randomised. Six participants have completed the first phase of the A-arm and 6 participants have completed the control period of the B-arm and their intervention is ongoing. Recruitment is ongoing. We expect the preliminary data from this study to be completed in 2026.

Conclusions:

This intervention will investigate whether whole body and gut MetFlex can be further explored and used as ex-ante predictors of successful weight loss following exercise and dietary interventions, providing proof of concept and paving the way for personalised lifestyle interventions. Clinical Trial: NCT06329349


 Citation

Please cite as:

Ludlova M, Koudelkova K, Pallova J, Koudelkova B, Siklova M, Cahova M, Vetrovsky T, Šteffl M, Gojda J

Metabolic Flexibility to Predict Lifestyle Interventions Outcomes (MEPHISTO): Protocol for Predictive Validation Study and Randomized Controlled Trial

JMIR Res Protoc 2025;14:e67570

DOI: 10.2196/67570

PMID: 40340957

PMCID: 12099273

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.